Harmaline

1. 2026-10-19issueIssued emergency
2. 2026-10-19issueIssued info_card
3. 2026-10-19issueIssued notice
4. 2026-09-07src5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO)
5. 2026-09-07srcHarmaline attenuates pain and inflammation: role of IL-1beta, oxidative stress, nitric oxide and cyclo-oxygenase
6. 2026-09-07srcIncreased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
7. 2026-09-07srcExamining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: a factorial dose-escalation study
8. 2026-09-07srcRecent pharmacological developments in beta-carboline alkaloid harmaline
9. 2026-09-07srcbeta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
10. 2026-09-07srcBanisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease
11. 2026-09-07srcSynergistic anxiolytic-like effect of CPPG and harmaline in non-stressed and acute restraint stress (ARS) mice
12. 2026-09-07srcThe effect of memantine in harmaline-induced tremor and neurodegeneration
13. 2026-09-07srcRapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
14. 2026-09-07srcMonoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter.
15. 2026-09-07srcThe alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro
16. 2026-09-07srcMultianalytical investigation reveals psychotropic substances in a Ptolemaic Egyptian vase
17. 2026-09-07srcCa(V)3.1 is a tremor rhythm pacemaker in the inferior olive
18. 2026-09-07srcRitualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose
19. 2026-09-07srcIndolealkylamines: biotransformations and potential drug-drug interactions
20. 2026-09-07srcAntidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
21. 2026-09-07srcAntidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies
22. 2026-09-07srcAyahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
23. 2026-09-07srcExposure Characteristics of the Analogous Beta-Carboline Alkaloids Harmaline and Harmine Based on the Efflux Transporter of Multidrug Resistance Protein 2
24. 2026-09-07srcThe Plant Alkaloid Harmaline Blocks the Voltage-Gated Sodium Channel Nav1.7: A Study Using an Automated Patch-Clamp
25. 2026-09-07srcIn Vitro Study of the Bioavailability and Bioaccessibility of the Main Compounds Present in Ayahuasca Beverages
26. 2026-09-07srcPharmacological and therapeutic effects of Peganum harmala and its main alkaloids
27. 2026-09-07srcHarmaline tremor: underlying mechanisms in a potential animal model of essential tremor
28. 2026-09-07srcProtective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes
29. 2026-09-07srcCharacterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine
30. 2026-09-07srcContribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine
31. 2026-09-07srcHuman pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
32. 2026-09-07srcDaytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
33. 2026-09-07srcBehavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus
34. 2026-09-07srcInvestigation of hallucinogenic and related beta-carbolines
35. 2026-09-07srcDiscovery and Isolation of Harmaline - Technical and Historical Guide
36. 2026-09-07srcHarmaline - Wikipedia
37. 2026-09-07srcLegal Status of Syrian Rue and Harmala Alkaloids
38. 2026-09-07srcPubChem Compound: Harmaline (CID 3564)
39. 2026-09-04issueIssued emergency
40. 2026-09-04issueIssued info_card
41. 2026-09-04issueIssued notice
42. 2026-06-04proposal35 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
43. 2026-06-04publicationPublication — backfill
44. 2026-05-07revisionRevision 1
45. 2026-05-07absenceSearched Multiple sources for "harmaline dose duration data compilation" — no results
46. 2026-05-07genGeneration — pipeline-v5 · with 2 morepipeline-v5
47. 2026-05-07rungeneration run

The same entries, as forms: six forms.